BACKGROUND: IL-17-producing gammadeltaT cells (gammadeltaT17) promote autoinflammatory diseases and cancers. Yet, gammadeltaT17 peripheral regulation has not been thoroughly explored especially in the context of microbiota-host interaction. The potent antigen-presenting CD103+ dendritic cell (DC) is a key immune player in close contact with both gammadeltaT17 cells and microbiota. This study presents a novel cellular network among microbiota, CD103+ DCs, and gammadeltaT17 cells. METHODS: Immunophenotyping of IL-17r-/- mice and IL-17r-/- IRF8-/- mice were performed by ex vivo immunostaining and flow cytometric analysis. We observed striking microbiome differences in the oral cavity and gut of IL-17r-/- mice by sequencing 16S rRNA gene (v1-v3 region) and analyzed using QIIME 1.9.0 software platform. Principal coordinate analysis of unweighted UniFrac distance matrix showed differential clustering for WT and IL-17r-/- mice. RESULTS: We found drastic homeostatic expansion of gammadeltaT17 in all major tissues, most prominently in cervical lymph nodes (cLNs) with monoclonal expansion of Vgamma6 gammadeltaT17 in IL-17r-/- mice. Ki-67 staining and in vitro CFSE assays showed cellular proliferation due to cell-to-cell contact stimulation with microbiota-activated CD103+ DCs. A newly developed double knockout mice model for IL-17r and CD103+ DCs (IL-17r-/-IRF8-/-) showed a specific reduction in Vgamma6 gammadeltaT17. Vgamma6 gammadeltaT17 expansion is inhibited in germ-free mice and antibiotic-treated specific pathogen-free (SPF) mice. Microbiota transfer using cohousing of IL-17r-/- mice with wildtype mice induces gammadeltaT17 expansion in the wildtype mice with increased activated CD103+ DCs in cLNs. However, microbiota transfer using fecal transplant through oral gavage to bypass the oral cavity showed no difference in colon or systemic gammadeltaT17 expansion. CONCLUSIONS: These findings reveal for the first time that gammadeltaT17 cells are regulated by microbiota dysbiosis through cell-to-cell contact with activated CD103+ DCs leading to drastic systemic, monoclonal expansion. Microbiota dysbiosis, as indicated by drastic bacterial population changes at the phylum and genus levels especially in the oral cavity, was discovered in mice lacking IL-17r. This network could be very important in regulating both microbiota and immune players. This critical regulatory pathway for gammadeltaT17 could play a major role in IL-17-driven inflammatory diseases and needs further investigation to determine specific targets for future therapeutic intervention.

Author Info: (1) Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA. (2) Department of Medicine, James Graham Brown Cancer Center, Unive rsity of Louisville School of Medicine, Louisville, KY, USA. (3) Department of Medicine, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, USA. (4) Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA. (5) Department of Medicine, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, USA. (6) Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA. (7) Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA. (8) Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA. (9) Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA. (10) Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA. (11) Department of Oncology, Zhejiang University the Second Affiliated Hospital, Hangzhou, China. (12) Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA. jun.yan@louisville.edu. Department of Medicine, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, USA. jun.yan@louisville.edu. Tumor Immunobiology Program, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, USA. jun.yan@louisville.edu.